89bio, Inc. (ETNB) Misses Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts ETNB Hot Sheet
Join SI Premium – FREE
89bio, Inc. (NASDAQ: ETNB) reported Q4 EPS of ($0.50), $0.01 worse than the analyst estimate of ($0.49).
For earnings history and earnings-related data on 89bio, Inc. (ETNB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Is the global equity rally broadening? UBS weighs in
- The Buckle (BKE) Tops Q2 EPS by 7c, Beats on Revenue
- RenovoRx regains Nasdaq minimum bid price compliance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
